Article
RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen.
Transfusion - 1 Jan 2020
Hayakawa Akira, Sano Rie, Takahashi Yoichiro, Kubo Rieko, Harada Megumi, Omata Masato, Yokohama Akihiko, Handa Hiroshi, Tsukada Junichi, Takeshita Haruo, Tsuneyama Hatsue, Ogasawara Kenichi, Kominato Yoshihiko
Abstract excerpt
BACKGROUND: Loss of blood group ABO antigens on red blood cells (RBCs) is well known in patients with leukemias, and such decreased ABO expression has been reported to be strongly associated with hypermethylation of the ABO promoter. We investigated the underlying mechanism responsible for A-antigen reduction on RBCs in a patient with myelodysplastic syndrome. STUDY DESIGN AND METHODS: Genetic analysis of ABO was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
